Polymer–Surfactant System Based Amorphous Solid Dispersion: Precipitation Inhibition and Bioavailability Enhancement of Itraconazole
Abstract
Share and Cite
Feng, D.; Peng, T.; Huang, Z.; Singh, V.; Shi, Y.; Wen, T.; Lu, M.; Quan, G.; Pan, X.; Wu, C. Polymer–Surfactant System Based Amorphous Solid Dispersion: Precipitation Inhibition and Bioavailability Enhancement of Itraconazole. Pharmaceutics 2018, 10, 53. https://doi.org/10.3390/pharmaceutics10020053
Feng D, Peng T, Huang Z, Singh V, Shi Y, Wen T, Lu M, Quan G, Pan X, Wu C. Polymer–Surfactant System Based Amorphous Solid Dispersion: Precipitation Inhibition and Bioavailability Enhancement of Itraconazole. Pharmaceutics. 2018; 10(2):53. https://doi.org/10.3390/pharmaceutics10020053
Chicago/Turabian StyleFeng, Disang, Tingting Peng, Zhengwei Huang, Vikramjeet Singh, Yin Shi, Ting Wen, Ming Lu, Guilan Quan, Xin Pan, and Chuanbin Wu. 2018. "Polymer–Surfactant System Based Amorphous Solid Dispersion: Precipitation Inhibition and Bioavailability Enhancement of Itraconazole" Pharmaceutics 10, no. 2: 53. https://doi.org/10.3390/pharmaceutics10020053
APA StyleFeng, D., Peng, T., Huang, Z., Singh, V., Shi, Y., Wen, T., Lu, M., Quan, G., Pan, X., & Wu, C. (2018). Polymer–Surfactant System Based Amorphous Solid Dispersion: Precipitation Inhibition and Bioavailability Enhancement of Itraconazole. Pharmaceutics, 10(2), 53. https://doi.org/10.3390/pharmaceutics10020053
